Aytu biopharma announces 1-for-20 reverse stock split

Englewood, co / accesswire / january 5, 2023 / aytu biopharma, inc. (the company or "aytu") (nasdaq:aytu), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, today announced a 1-for-20 reverse stock split of its outstanding common stock, effective at 12:01 a.m. eastern time on january 6, 2023.

AYTU Ratings Summary

AYTU Quant Ranking